Following, we explored the relationships of IL2RA with anti-cancer immunity responses, abundances of TIICs, and immunotherapy-predicted pathways, demonstrating that high IL2RA expression in PDAC was associated with activated anti-cancer immune activities, TIICs, and immunotherapy responses. Here, IL2RA is linked to cancer.